ASH 2017 Highlights: CAR-T Competition, Myeloma, Hemophilia & More
Xconomy
DECEMBER 11, 2017
Note: Ben Fidler co-authored this report.] Non-Hodgkin Lymphoma The first competition in the CAR-T field will be in adult non-Hodgkin lymphoma. Gene therapy and more standard forms of care are up for discussion, too. If you’re not ASH-saturated by now, stay tuned: We’ll have more hematology coverage later this week.
Let's personalize your content